with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product...

8437°E / 45.727; 4.8437 Sanofi Pasteur is the vaccines division of the French multinational pharmaceutical company Sanofi. Sanofi Pasteur is the largest...

With the new company's 2004 merger with Sanofi-Synthélabo, it became a subsidiary of the resulting Sanofi-Aventis pharmaceuticals group. The company...

The Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19...

Amgen Inc. v. Sanofi, 598 U.S. 594 (2023), is a United States Supreme Court case in which the Court held that Amgen's two patent applications on cholesterol-lowering...

Depakin (Sanofi S.R.L. Italy) Depakine (Sanofi Aventis France) Depakine (Sanofi Synthelabo Romania) Depalept (Sanofi Aventis Israel) Deprakine (Sanofi Aventis...

The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate...

2020" (PDF). "Sanofi Form 20-F 2019" (PDF). "Sanofi Form 20-F 2018" (PDF). "Sanofi Form 20-F 2017" (PDF). "Sanofi Form 20-F 2016" (PDF). "Sanofi Form 20-F...

cell called eosinophils. It was developed by Regeneron Pharmaceuticals and Sanofi Genzyme. It received approval from the US Food and Drug Administration (FDA)...

innovators. In February 2022, Sanofi's new corporate brand was unveiled and former entity "Sanofi Genzyme" got integrated into Sanofi. The company was started...